On September 10, 2026, Joby Aviation, Inc., (the "Company") filed a prospectus supplement pursuant to Rule 424(b) under the Securities Act of 1933, as amended (the "Act"), with the U.S. Securities and Exchange Commission (the "Commission") relating to the resale of 2,419,801 shares of common stock, $0.0001 par value per share ("common stock"), of the Company that were issued by the Company to the selling stockholder named therein in connection with the achievement of certain EBITDA milestones by the acquired operations during the 12-month period following the closing of the acquisition of the passenger segment and operations of Strata Critical Medical, Inc. (f/k/a Blade Air Mobility, Inc.), Trinity Medical Intermediate II, Inc., and Blade Urban Air Mobility, Inc.. The prospectus supplement forms a part of the Company’s Registration Statement on Form S-3 (No. 333-282809), which was originally filed with the Commission on October 24, 2024 (the "Registration Statement").